Pfizer introduces the "slow turkey" way to quit smoking in its latest TV commercial for cessation drug Chantix.
When it comes to reducing drug prices, doctors think pharma should go on a DTC diet.
Allogene Therapeutics is looking to use donated T cells that may simplify the very complex CAR T treatment manufacturing processes.
Pfizer moved rheumatoid arthritis patients to a lower Xeljanz dose after a data monitoring board highlighted safety concerns for the 10-mg arm.
Bausch Health is working to pay down debt and focusing on "organic growth," but one analyst says the company hasn't changed much from the old…
Years after Teva entered an FTC settlement on "pay-for-delay" deals, the parties on Tuesday expanded the agreement.
M&A will help the biopharma industry deal with significant new challenges, Morningstar said, including pressure from lawmakers and payers to lower prices.
Merck’s Keytruda has been hitting its trial targets so often, it’s tempting to think it can't miss. But Tuesday’s data in liver cancer shows it can.
A CDMO that has made a habit of snapping up Big Pharma’s discarded manufacturing plants has put a former AstraZeneca plant into bankruptcy.
Activist hedge fund Starboard Value may be trying to thwart the $74 billion buyout of Celgene by finding a buyer for BMS, some analysts speculate.
